Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › fenofibrate

fenofibrate

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of fenofibrate

24 trials tracked of fenofibrate: 12 in phase 3 or 4 and 4 with published results. The most-cited published study has 126 citations.

24Trials tracked
12Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 6 Phase 3 6 Phase 2 6 Phase 1 1 Other / NA 5
  1. Phase 4 Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) Completed · 126 cited
  2. Phase 4 Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia Completed · 86 cited
  3. Phase 3 An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia Completed · 39 cited
  4. Phase 3 An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Completed · 31 cited
  5. Phase 4 Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females Completed
  6. Phase 4 Fenofibrate in Type 2 Diabetes Completed
Show 18 more trials
  1. Phase 4 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic Completed
  2. Phase 4 The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans Completed
  3. Phase 3 Fenofibrate Treatment in SCI Completed
  4. Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment Completed
  5. Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function Completed
  6. Phase 3 Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) Completed
  7. Phase 2 Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease Completed
  8. Phase 2 An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Completed
  9. Phase 2 Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents Completed
  10. Phase 2 Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate Completed
  11. Phase 2 Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer Completed
  12. Phase 2 Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia Completed
  13. Phase 1 Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function Completed
  14. N/A Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate Completed
  15. N/A Obesity and Nonalcoholic Fatty Liver Disease Completed
  16. N/A Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia Completed
  17. N/A Lipid Biomarkers for Diabetic Heart Disease Completed
  18. N/A Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides. Completed

Showing the 24 most-cited and recently-updated of 24 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cerivastatin best for total cholesterol, simvastatin for LDL-C in DKD with hyperlipidemia
Diabetes & Endocrinology Meta-analysis
Cerivastatin best for total cholesterol, simvastatin for LDL-C in DKD with hyperlipidemia Lipid-Lowering Drugs Show Different Benefits for Kidney Disease
A network meta-analysis of 20 RCTs in patients with diabetic kidney disease and hyperlipidemia found that cerivastatin most effectively redu…
A review of 20 trials found that different statins and fenofibrate have unique effects on cholesterol, kidney markers, and heart risks in di…
Frontiers May 29, 2026
Review summarizes fenofibrate, metformin, and MSC modulation in Primary Sjögren disease management
Hematology Sys. Review
Review summarizes fenofibrate, metformin, and MSC modulation in Primary Sjögren disease management The Dry Mouth Disease Has an Immune Fix Researchers Didn't Expect
This review examines the potential of fenofibrate, metformin, and mesenchymal stem cells in Primary Sjögren disease management.
Three existing drugs may restore the immune balance broken in Sjögren's disease, a chronic condition that destroys saliva and tear glands.
Frontiers Apr 18, 2026
PPARα rs6008845 genotype modifies fenofibrate benefit for vascular events in type 2 diabetes
Diabetes & Endocrinology RCT
PPARα rs6008845 genotype modifies fenofibrate benefit for vascular events in type 2 diabetes Genetic variant linked to diabetes risks and fenofibrate benefits in FIELD study
This RCT substudy of 8,159 adults with type 2 diabetes examined the PPARα rs6008845 genotype and fenofibrate treatment.
A specific gene variant increases diabetes complication risks, but fenofibrate treatment benefits remain consistent across all genetic group…
Apr 9, 2026